Life Sciences

All articles by Life Sciences

Flagship’s Generate:Biomedicines closes $273M Series C funding round
Flagship’s Generate:Biomedicines closes $273M Series C funding round
Jack O'Brien
September 14, 2023
1:39 pm

This marks Generate:Biomedicines’ first funding round since recording a $370 million Series B financing effort in late 2021.

Danaher beats out rivals to buy life sciences supplier Abcam for $5.7B
Danaher beats out rivals to buy life sciences supplier Abcam for $5.7B
Lecia Bushak
August 28, 2023
1:23 pm

Danaher will pick up Abcam for $24 per share in cash, aiming to expand its medical supply offering with Abcam’s expertise in antibodies and assays used in research.

Havas Health & You’s Archipelago expands globally
Havas Health & You’s Archipelago expands globally
Jack O'Brien
July 19, 2023
4:39 pm

To support the Havas expansion, Archipelago hired Daniela Ritrovato and Jaineel Mistry to serve as directors of value and access consulting.

Pfizer strikes partnership with Flagship Pioneering that could reach $7B
Pfizer strikes partnership with Flagship Pioneering that could reach $7B
Lecia Bushak
July 18, 2023
12:51 pm

Pfizer will be able to use Flagship Pioneering’s large ecosystem of 40 biotech companies and platforms to help explore opportunities for the burgeoning programs.

PwC: Pharma and life sciences deal value and volumes slide to start 2023
PwC: Pharma and life sciences deal value and volumes slide to start 2023
Jack O'Brien
June 22, 2023
7:00 am

PwC’s report aligns with recent assessments of the pharma and biotech sector’s interest in dealmaking despite industry-related pressures.

PerkinElmer’s life science and diagnostics spinoff rebrands as Revvity
PerkinElmer’s life science and diagnostics spinoff rebrands as Revvity
Jack O'Brien
May 11, 2023
10:44 am

As it relates to the existing brand architecture, Revvity said its BioLegend, Euroimmun, Tulip Diagnostics and ViaCord franchises will retain their respective names as unique product lines.

Sartorius to pick up French drugmaker Polyplus for $2.6B
Sartorius to pick up French drugmaker Polyplus for $2.6B
Jack O'Brien
March 31, 2023
11:52 am

Polyplus is expected to generate sales revenue in the “upper double-digit million-euro range” along with a “very substantial” EBITDA margin this year.

Life science companies can now create personalized virtual worlds with Indegene’s metaverse capabilities
Life science companies can now create personalized virtual worlds with Indegene’s metaverse capabilities
Lecia Bushak
February 21, 2023
11:38 am

Indegene said its recently launched metaverse capabilities will include HCP interactions and patient education.

‘Ignore the hype’ and get practical: How life science firms can take advantage of metaverse opportunities
‘Ignore the hype’ and get practical: How life science firms can take advantage of metaverse opportunities
Lecia Bushak
February 2, 2023
4:35 pm

A report out of Cognizant hones in on how life science companies can take a ‘pragmatic approach’ to the metaverse.

Can an in-person JPM supercharge biopharma deal-making?
Can an in-person JPM supercharge biopharma deal-making?
Marc Iskowitz
January 9, 2023
5:30 am

The largest gathering in the life sciences sector returns to its in-person format today, which should help deal-making rebound from a down year.

  • From Our Partners